PMID- 17305405 OWN - NLM STAT- MEDLINE DCOM- 20070515 LR - 20220330 IS - 0893-228X (Print) IS - 0893-228X (Linking) VI - 20 IP - 2 DP - 2007 Feb TI - Role of IL-6 in an IL-10 and IL-4 double knockout mouse model uniquely susceptible to acetaminophen-induced liver injury. PG - 208-16 AB - Drug-induced hepatitis remains a challenging problem for drug development and safety because of the lack of animal models. In the current work, we discovered a unique interaction that makes mice deficient in both IL-10 and IL-4 (IL-10/4-/-) highly sensitive to the hepatotoxic effects of acetaminophen (APAP). Male C57Bl/6 wild type (WT) and mice deficient in one or more cytokines were treated with 120 mg/kg APAP. Within 24 h after WT, IL-10-/-, IL-4-/-, or IL-10/4-/- mice were administered APAP, 75% of the IL-10/4-/- mice died of massive hepatic injury while all other genotypes were resistant to liver toxicity at this dose of APAP. The unique susceptibility of IL-10/4-/- mice was associated with reduced levels of liver glutathione and remarkably high serum levels of IL-6 and several proinflammatory factors including TNF-alpha, IFN-gamma, macrophage inflammatory protein-1alpha (MIP-1alpha), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-2 (MIP-2), and osteopontin (OPN) as well as nitric oxide (NO). IL-6 appeared to have a causal role in controlling the unique susceptibility of IL-10/4-/- mice to APAP-induced liver disease (AILD) because IL-6 neutralizing antibody reversed the high sensitivity of these mice to AILD. Moreover, IL-10/4/6-/- mice were also resistant to the enhanced susceptibility to AILD and expressed relatively low levels of most proinflammatory factor genes that were elevated in the IL-10/4-/- mice. In conclusion, liver homeostasis following AILD appears to be highly dependent on the activities of both IL-10 and IL-4, which together help prevent overexpression of IL-6 and other potential hepatotoxic factors. FAU - Bourdi, Mohammed AU - Bourdi M AD - Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. bourdim@nih.gov FAU - Eiras, Daniel P AU - Eiras DP FAU - Holt, Michael P AU - Holt MP FAU - Webster, Marie R AU - Webster MR FAU - Reilly, Timothy P AU - Reilly TP FAU - Welch, Kevin D AU - Welch KD FAU - Pohl, Lance R AU - Pohl LR LA - eng GR - Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Intramural PL - United States TA - Chem Res Toxicol JT - Chemical research in toxicology JID - 8807448 RN - 0 (Antibodies) RN - 0 (Biomarkers) RN - 0 (Interleukin-6) RN - 130068-27-8 (Interleukin-10) RN - 207137-56-2 (Interleukin-4) RN - 31C4KY9ESH (Nitric Oxide) RN - 362O9ITL9D (Acetaminophen) RN - 9008-11-1 (Interferons) RN - EC 3.5.3.1 (Arginase) RN - GAN16C9B8O (Glutathione) SB - IM MH - Acetaminophen/administration & dosage/*toxicity MH - Animals MH - Antibodies/pharmacology MH - Arginase/antagonists & inhibitors/biosynthesis MH - Biomarkers/blood MH - Chemical and Drug Induced Liver Injury/blood/*metabolism/pathology MH - *Disease Models, Animal MH - Genetic Predisposition to Disease MH - Glutathione/drug effects/metabolism MH - Interferons/biosynthesis MH - Interleukin-10/*deficiency/genetics MH - Interleukin-4/*deficiency/genetics MH - Interleukin-6/antagonists & inhibitors/blood/*physiology MH - Liver/drug effects/metabolism/pathology MH - Mice MH - Mice, Knockout MH - Nitric Oxide/biosynthesis/blood EDAT- 2007/02/20 09:00 MHDA- 2007/05/16 09:00 CRDT- 2007/02/20 09:00 PHST- 2007/02/20 09:00 [pubmed] PHST- 2007/05/16 09:00 [medline] PHST- 2007/02/20 09:00 [entrez] AID - 10.1021/tx060228l [doi] PST - ppublish SO - Chem Res Toxicol. 2007 Feb;20(2):208-16. doi: 10.1021/tx060228l.